Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.4 USD | -1.00% | -6.69% | +17.94% |
04-30 | Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals | MT |
04-30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+17.94% | 3.8B | |
+18.71% | 47.02B | |
+48.77% | 41.86B | |
+0.37% | 41.76B | |
-4.27% | 28.8B | |
+11.87% | 26.05B | |
-22.27% | 19.15B | |
+4.34% | 12.55B | |
+29.31% | 12.34B | |
-3.92% | 11.82B |
- Stock Market
- Equities
- ALVO Stock
- News Alvotech
- Transcript : Alvotech - Special Call